Viewing Study NCT06424210



Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06424210
Status: COMPLETED
Last Update Posted: 2024-05-22
First Post: 2024-05-13

Brief Title: The Role of Surgery for Esophageal Cancer With Metastatic Disease M1
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Study Overview

Official Title: The Role of Surgery for Esophageal Cancer With Metastatic Disease M1
Status: COMPLETED
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Treatment of stage IV esophageal cancer is traditionally palliative but treatment response is usually poor The role of surgery in the treatment of advanced esophageal cancer remains controversial We sought to determine whether surgical treatment followed by neoadjuvant chemoradiation therapy might provide survival benefits for these patients

A retrospective review of esophageal cancer patients with M1 disease treated at National Taiwan University Hospital was performed from April 2002 to June 2021 Patient demographics and cancer staging treatment and disease recurrence and time of follow up were included for analysis Univariate and multivariate analysis was performed for overall survival and progression-free survival analysis Propensity score matching based on patient age and tumor staging characteristics was also performed for analysis
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None